The Ph translocation creates the BCR-ABL fusion protein, with nearly all CML patients harboring a breakpoint that results in a 210-kD protein (BCR-ABLp210). Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.